Skip to main content

Sitting Too Much May Boost Odds of Dying

March 26, 2012 — Don't take this sitting down, but spending too much time in a chair is bad for your health -- really, really bad.
New research published in the Archives of Internal Medicine shows that people who spend a lot of time sitting may be up to 40% more likely to die from any cause, compared to people who don't sit as long.
The study tracked nearly 222,500 Australian adults for about three years. During that time, people's odds of dying dovetailed with how much time they spent sitting.
Compared to people who spent less than four hours per day sitting, the odds of dying were:
  • 15% higher for people who sat for at least eight hours
  • 40% higher for people who sat for 11 or more hours a day
“Our findings add to the mounting evidence that public health programs should focus not just on increasing population physical activity levels, but also on reducing sitting time,” the researchers write.
Alpa V. Patel, PhD, has published studies on the health risks associated with too much sitting. She is an epidemiologist at the American Cancer Society in Atlanta. “We are continuing to demonstrate time and time again in different populations that there is something real to the association between sitting time and reduced longevity.”
Get Up Out of That Chair
What's so bad about sitting for long periods? That's not totally clear. But exercise and movement do have a positive effect on blood fats called triglycerides and other heart risks, and improves blood pressure, Patel says.
Her advice: Sit for five fewer minutes per hour. “Small changes can have a big impact," she says.
Technology may fight that. It's given us fewer reasons to move, says David A. Friedman, MD. He is the chief of heart failure services at North Shore Plainview Hospital in Plainview, N.Y.
Instead of texting or emailing a colleague, “walk down a few cubicles and say, ‘Hi, how are you?’ This is good face time and it’s also good exercise.”
Olveen Carrasquillo, MD, MPH, is the chief of the division of general internal medicine at the University of Miami’s Miller School of Medicine. “A sedentary lifestyle is not good for your health,” he says. “Today we don’t even have to leave the house to go to the bank or mail a letter.”
The new study doesn't prove that sitting killed people. It's not clear which came first -- poorer health or spending more time in a chair.
Still, there's no doubt that movement is good for many reasons.
“It is hard to say whether someone is fairly sedentary because they are inactive or if they are inactive because of other things, such as an unhealthy lifestyle that includes smoking," says Scott Kahan, MD, MPH. He is the director of the National Center for Weight and Wellness in Washington, D.C.
Still, there is no doubt that being active is healthy. “The key is to do something you like to do, whether it’s sports, going to the gym, walking, or gardening. “If it is terribly unenjoyable, the likelihood of sustaining it is pretty low.”
SOURCES:
Van der Ploeg, H. Archives of Internal Medicine, 2012.
Dunstan, D. Archives of Internal Medicine, 2012.
Scott Kahan, MD, MPH, director, National Center for Weight and Wellness, Washington D.C.
David A. Friedman, MD, chief of heart failure services, North Shore Plainview Hospital, Plainview, N.Y.
Alpa V. Patel, PhD, epidemiologist, American Cancer Society, Atlanta, Ga.
Olveen Carrasquillo, MD, chief, division of general medicine, University of Miami Miller School of Medicine, Miami, Fla.

Authors and Disclosures

Journalist

Denise Mann

Denise Mann is a freelance medical writer.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n